{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:30:35Z","timestamp":1793403035065,"version":"4.5.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Autoimmune rheumatic diseases (ARDs), including rheumatoid arthritis and osteoarthritis, are debilitating conditions with limited curative options. Stem cell therapy offers promising regenerative and immunomodulatory benefits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We analyzed global clinical trial data from the Informa Trialtrove database up to 31 March 2025, identifying 449 relevant trials on stem cell therapy for ARDs. Trials were assessed by phase, disease type, stem cell source, and geographic distribution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Most trials employed mesenchymal stem cells (75.8%), with osteoarthritis (46.7%) and rheumatoid arthritis (12.6%) being the most targeted conditions. China led trial activity (26.7%), driven by supportive policies and funding. While 58.8% of trials were completed, 13.1% were terminated, often due to recruitment or funding limitations. Innovations such as CAR-MSCs, iPSC-derived therapies, and exosome-based strategies are expanding the therapeutic frontier.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Stem cell therapy is rapidly advancing in ARDs, supported by growing clinical evidence and technological innovations. However, standardized, multicenter phase III trials are essential to confirm long-term efficacy and safety. This evolving landscape holds potential to transform AIRD management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003130","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:34Z","timestamp":1756339234000},"page":"9757-9760","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical trial landscape analysis of stem cell therapy for autoimmune rheumatic diseases"],"prefix":"10.1097","volume":"111","author":[{"given":"Jia","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Traditional Chinese Medicine, Jiangxi Maternal and Child Health Hospital, Nanchang University School of Medicine, Nanchang, China"},{"name":"Department of Traditional Chinese Medicine, Key Laboratory of Women\u2019s Reproductive Health of Jiangxi Province, Jiangxi Maternal and Child Health Hospital, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Jiangxi Maternal and Child Health Hospital, Nanchang University School of Medicine, Nanchang, China"},{"name":"Department of Traditional Chinese Medicine, Key Laboratory of Women\u2019s Reproductive Health of Jiangxi Province, Jiangxi Maternal and Child Health Hospital, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Jiangxi Maternal and Child Health Hospital, Nanchang University School of Medicine, Nanchang, China"},{"name":"Department of Traditional Chinese Medicine, Key Laboratory of Women\u2019s Reproductive Health of Jiangxi Province, Jiangxi Maternal and Child Health Hospital, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Jiangxi Maternal and Child Health Hospital, Nanchang University School of Medicine, Nanchang, China"},{"name":"Department of Traditional Chinese Medicine, Key Laboratory of Women\u2019s Reproductive Health of Jiangxi Province, Jiangxi Maternal and Child Health Hospital, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Jiangxi Maternal and Child Health Hospital, Nanchang University School of Medicine, Nanchang, China"},{"name":"Department of Traditional Chinese Medicine, Key Laboratory of Women\u2019s Reproductive Health of Jiangxi Province, Jiangxi Maternal and Child Health Hospital, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"R1-20261030","first-page":"100082","article-title":"Transparency in the reporting of artificial intelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R2-20261030","first-page":"245\u201348","article-title":"Emerging trends in autoimmune rheumatic diseases treatment: a new era of personalized medicine","volume":"19","author":"Baoro","year":"2024","journal-title":"Int J Clin Rheumatol"},{"key":"R3-20261030","doi-asserted-by":"crossref","first-page":"e70189","DOI":"10.1002\/iid3.70189","article-title":"Clinical progress in mesenchymal stem cell therapy: a focus on rheumatic diseases","volume":"13","author":"Hetta","year":"2025","journal-title":"Immun Inflamm Dis"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"1252\u201363","DOI":"10.1016\/j.jcyt.2024.05.016","article-title":"Unlocking the full potential of mesenchymal stromal cell therapy for osteoarthritis through machine learning-based in silico trials","volume":"26","author":"Yin","year":"2024","journal-title":"Cytotherapy"},{"key":"R5-20261030","first-page":"244\u201360","article-title":"Leveraging generative AI for precision medicine: interpreting immune biomarker data from EHRs in autoimmune and infectious diseases","volume":"6","author":"Shiwlani","year":"2025","journal-title":"Ann Hum and Soc Sci"},{"key":"R7-20261030","doi-asserted-by":"crossref","first-page":"626\u201350","DOI":"10.1038\/s41423-023-01020-1","article-title":"Culture-expanded mesenchymal stromal cell therapy: does it work in knee osteoarthritis? A pathway to clinical success","volume":"20","author":"Copp","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"R8-20261030","doi-asserted-by":"crossref","first-page":"443\u201360","DOI":"10.1038\/s41551-024-01195-6","article-title":"Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression","volume":"8","author":"Sirpilla","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"15281\u2013301","DOI":"10.1021\/acsnano.4c13492","article-title":"Three-dimensional bioprinting of growth differentiation factor 5-preconditioned mesenchymal stem cell-derived exosomes facilitates articular cartilage endogenous regeneration","volume":"19","author":"Zheng","year":"2025","journal-title":"ACS Nano"},{"key":"R10-20261030","doi-asserted-by":"crossref","first-page":"e001197","DOI":"10.1136\/lupus-2024-001197","article-title":"Metabolomic analysis suggests thiamine monophosphate as a potential marker for mesenchymal stem cell transplantation outcomes in patients with SLE","volume":"12","author":"Jiang","year":"2025","journal-title":"Lupus Sci Med"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000003130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:00:22Z","timestamp":1793401222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000003130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003130","relation":{},"ISSN":["1743-9159","1743-9191"],"issn-type":[{"value":"1743-9159","type":"electronic"},{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"2025-05-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}